These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
384 related articles for article (PubMed ID: 34041632)
1. Recent Advancement in Topical Nanocarriers for the Treatment of Psoriasis. Biswasroy P; Pradhan D; Kar B; Ghosh G; Rath G AAPS PharmSciTech; 2021 May; 22(5):164. PubMed ID: 34041632 [TBL] [Abstract][Full Text] [Related]
2. Development of Topical Gel of Methotrexate Incorporated Ethosomes and Salicylic Acid for the Treatment of Psoriasis. Chandra A; Aggarwal G; Manchanda S; Narula A Pharm Nanotechnol; 2019; 7(5):362-374. PubMed ID: 31490769 [TBL] [Abstract][Full Text] [Related]
3. Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis. Doppalapudi S; Jain A; Chopra DK; Khan W Eur J Pharm Sci; 2017 Jan; 96():515-529. PubMed ID: 27777066 [TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization, and Walunj M; Doppalapudi S; Bulbake U; Khan W J Liposome Res; 2020 Mar; 30(1):68-79. PubMed ID: 30897993 [TBL] [Abstract][Full Text] [Related]
5. A novel nanogel formulation of methotrexate for topical treatment of psoriasis: optimization, in vitro and in vivo evaluation. Avasatthi V; Pawar H; Dora CP; Bansod P; Gill MS; Suresh S Pharm Dev Technol; 2016 Aug; 21(5):554-62. PubMed ID: 26024238 [TBL] [Abstract][Full Text] [Related]
6. Nanocarriers Mediated Topical Drug Delivery for Psoriasis Treatment. Gungor S; Rezigue M Curr Drug Metab; 2017; 18(5):454-468. PubMed ID: 28228078 [TBL] [Abstract][Full Text] [Related]
7. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers. Pinto MF; Moura CC; Nunes C; Segundo MA; Costa Lima SA; Reis S Int J Pharm; 2014 Dec; 477(1-2):519-26. PubMed ID: 25445970 [TBL] [Abstract][Full Text] [Related]
8. Treatment Modalities of Psoriasis: A Focus on Requisite for Topical Nanocarrier. Ramanunny AK; Wadhwa S; Thakur D; Singh SK; Kumar R Endocr Metab Immune Disord Drug Targets; 2021; 21(3):418-433. PubMed ID: 32496998 [TBL] [Abstract][Full Text] [Related]
9. Novel drug delivery systems in topical treatment of psoriasis: rigors and vigors. Katare OP; Raza K; Singh B; Dogra S Indian J Dermatol Venereol Leprol; 2010; 76(6):612-21. PubMed ID: 21079304 [TBL] [Abstract][Full Text] [Related]
10. An Innovative Approach in Nanotechnology-based Delivery System for the Effective Management of Psoriasis. Parveen S; Ahmed M; Baboota S; Ali J Curr Pharm Des; 2022; 28(13):1082-1102. PubMed ID: 35105284 [TBL] [Abstract][Full Text] [Related]
11. Microemulsions mediated effective delivery of methotrexate hydrogel: more than a tour de force in psoriasis therapeutics. Amarji B; Garg NK; Singh B; Katare OP J Drug Target; 2016; 24(2):147-60. PubMed ID: 26204326 [TBL] [Abstract][Full Text] [Related]
12. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study. Abdelbary AA; AbouGhaly MH Int J Pharm; 2015 May; 485(1-2):235-43. PubMed ID: 25773359 [TBL] [Abstract][Full Text] [Related]
13. Novel Topical Nanocarriers for Treatment of Psoriasis: An Overview. Dadwal A; Mishra N; Narang RK Curr Pharm Des; 2018; 24(33):3934-3950. PubMed ID: 30387390 [TBL] [Abstract][Full Text] [Related]
14. Polymeric micelle nanocarriers for the cutaneous delivery of tacrolimus: a targeted approach for the treatment of psoriasis. Lapteva M; Mondon K; Möller M; Gurny R; Kalia YN Mol Pharm; 2014 Sep; 11(9):2989-3001. PubMed ID: 25057896 [TBL] [Abstract][Full Text] [Related]
15. Methotrexate in the Treatment of Psoriasis and Rheumatoid Arthritis: Mechanistic Insights, Current Issues and Novel Delivery Approaches. Rajitha P; Biswas R; Sabitha M; Jayakumar R Curr Pharm Des; 2017; 23(24):3550-3566. PubMed ID: 28571554 [TBL] [Abstract][Full Text] [Related]
16. Physico-chemical characteristics of methotrexate-entrapped oleic acid-containing deformable liposomes for in vitro transepidermal delivery targeting psoriasis treatment. Srisuk P; Thongnopnua P; Raktanonchai U; Kanokpanont S Int J Pharm; 2012 May; 427(2):426-34. PubMed ID: 22310459 [TBL] [Abstract][Full Text] [Related]
17. Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis. Bessar H; Venditti I; Benassi L; Vaschieri C; Azzoni P; Pellacani G; Magnoni C; Botti E; Casagrande V; Federici M; Costanzo A; Fontana L; Testa G; Mostafa FF; Ibrahim SA; Russo MV; Fratoddi I Colloids Surf B Biointerfaces; 2016 May; 141():141-147. PubMed ID: 26852097 [TBL] [Abstract][Full Text] [Related]
18. Recent Advancements and Trends of Topical Drug Delivery Systems in Psoriasis: A Review and Bibliometric Analysis. An P; Zhao Q; Hao S; Wang X; Tian J; Ma Z Int J Nanomedicine; 2024; 19():7631-7671. PubMed ID: 39099792 [TBL] [Abstract][Full Text] [Related]
19. Development and characterization of nanocarriers for topical treatment of psoriasis by using combination therapy. Parnami N; Garg T; Rath G; Goyal AK Artif Cells Nanomed Biotechnol; 2014 Dec; 42(6):406-12. PubMed ID: 24079701 [TBL] [Abstract][Full Text] [Related]
20. A Promising Approach of Dermal Targeting of Antipsoriatic Drugs Tripathi D; Srivastava M; Rathour K; Rai AK; Wal P; Sahoo J; Tiwari RK; Pandey P Drug Metab Bioanal Lett; 2023; 16(2):89-104. PubMed ID: 37534794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]